Skip to content
AnalystLens
Back to WSTCash Flow

West Pharmaceutical Services Free Cash Flow 2008-2026 | WST

Annual FY2008–FY2025 · quarterly through Q3 FY2026

Latest annual · FY2025

$468.9M

+69.6%YoY vs FY2024Source: 10-KFY2025

From −$3.6M in FY2008 to $468.9M in FY2025.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$47M−18.8%$81M−20.7%$150M+12.3%Not reported
FY25$58M+110.5%$102M+57.3%$134M+35.5%$175M+105.4%
FY24$28M−50.7%$65M−30.9%$99M−26.4%$85M−34.7%
FY23$56M−34.4%$94M−12.3%$134M+20.9%$130M−4.0%
FY22$85M+151.2%$107M+22.3%$111M−11.0%$136M+61.2%
Share12%27%31%31%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionStable
CAGR

+9.5%

FY2020
$298.1M
FY2025
$468.9M

5 years selected · on the chart

01—History

Free Cash Flow History

Year-over-year comparison from 10-K annual reports

  18. $468.9M
YoY changeLargest recent move+169.3%in FY17Latest +69.6%

2 older moves run past ±150% (largest +1011.1%); point at, tap or drag across the bars to read one.

02—Ledger

Free Cash Flow, period by period

PeriodValueChangeSource
FY2025$468.9M+69.6%10-K
FY2024$276.4M−33.3%10-K
FY2023$414.5M−5.7%10-K
FY2022$439.4M+32.9%10-K
FY2021$330.6M+10.9%10-K
FY2020$298.1M+23.8%10-K
FY2019$240.8M+30.9%10-K
FY2018$183.9M+38.8%10-K
FY2017$132.5M+169.3%10-K
FY2016$49.2M−39.1%10-K
FY2015$80.8M+13.8%10-K
FY2014$71.0M+3.5%10-K
FY2013$68.6M+22.3%10-K
FY2012$56.1M+58.9%10-K
FY2011$35.3M−47.5%10-K
FY2010$67.2M+104.9%10-K
FY2009$32.8M+1011.1%10-K
FY2008−$3.6M—10-K

03—Questions

What is West Pharmaceutical Services's current free cash flow?

West Pharmaceutical Services (WST) annual free cash flow for 2025 was $468.9M, a 69.65% increase from 2024. West Pharmaceutical Services free cash flow for the quarter ending September 30, 2026 was $150.4M.

What was West Pharmaceutical Services's free cash flow in 2024?

West Pharmaceutical Services annual free cash flow for 2024 was $276.4M, a 33.32% decline from 2023.

What was West Pharmaceutical Services's free cash flow in 2023?

West Pharmaceutical Services annual free cash flow for 2023 was $414.5M, a 5.67% decline from 2022.

What is West Pharmaceutical Services's 5-year free cash flow CAGR?

West Pharmaceutical Services free cash flow grew at a compound annual growth rate (CAGR) of 9.48% from FY2020 to FY2025, going from $298.1M to $468.9M over 5 years.

Company
West Pharmaceutical Services
Ticker
WST
Sector
Healthcare
Industry
Surgical & Medical Instruments & Apparatus
View company profile →